EP 36

Future of IND Filings

The use of AI and machine learning in regulatory affairs is revolutionizing the process of getting new medicines approved. From speeding up submissions to monitoring compliance and safety, AI is making the process faster, more efficient, and safer. In this episode, we dive deep into how AI is changing the rules of regulatory affairs and what it means for the future of drug development.

AIRegulatory AffairsIND FilingsFDAMachine LearningNatural Language ProcessingPredictive AI

play_arrowListen to episode

Key Concepts

AI in Regulatory Affairs

AI is being used to speed up regulatory submissions
AI is being used to monitor compliance and safety in real-time
AI is being used to improve manufacturing quality

Natural Language Processing (NLP)

NLP is being used to proofread submission documents
NLP is being used to check for inconsistencies in submission documents

Predictive AI

Predictive AI is being used to predict FDA questions
Predictive AI is being used to prepare responses to FDA questions in advance

FDA Framework for AI

The FDA is creating a credibility assessment framework for AI models
The framework requires transparency and documentation of AI models

Human Judgment and Oversight

Human judgment and oversight are essential in the use of AI in regulatory affairs
The FDA is emphasizing the importance of human judgment and oversight in the use of AI

Episode Summary

check_circleAI and machine learning are being used to speed up regulatory submissions, such as IND filings, by automating tasks like writing and proofreading
check_circleAI can compile and check data, reducing the time it takes to prepare submissions and minimizing errors
check_circleNatural language processing (NLP) is being used to proofread submission documents and check for inconsistencies
check_circlePredictive AI is being used to predict FDA questions and prepare responses in advance, reducing response times and follow-up questions
check_circleAI is being used to monitor compliance and safety in real-time, tracking regulatory updates and identifying potential risks
check_circleAI is being used to improve manufacturing quality, such as inspecting tablets and vials for defects
check_circleThe FDA is creating a framework for the use of AI in regulatory affairs, including a credibility assessment framework for AI models
check_circleThe framework requires transparency and documentation of AI models, including their architecture, training data, and testing
check_circleThe FDA is also emphasizing the importance of human judgment and oversight in the use of AI in regulatory affairs

Full Transcript

Discussion

Join the discussion — sign in to leave a comment.